Witold W. Kilarski

Witold W. Kilarski

Auto-generated profile, based on publicly available information

Witold W. Kilarski

Institute for Molecular Engineering, The University of Chicago, Chicago, IL, USA

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2014 in Science
Verified
Journal Article
Closed access
PDF file
MMMikaël M. Martino
Mikaël M. Martino
PBPriscilla S. Briquez
Priscilla S. Briquez
EGEsra Güç
Esra Güç
FTFederico Tortelli
Federico Tortelli
WKWitold W. Kilarski
Witold W. Kilarski
JHJeffrey A. Hubbell
Jeffrey A. Hubbell
Toward Successful Tissue Repair: The therapeutic use of growth factors in tissue regeneration has suffered from safety and efficacy issues. Reasoning that the unmet potential may be because of nonphysiological delivery, Martino et al. (p. 885 ) engineered growth factors to bind strongly to extracellular matrix proteins. These variants were able to induce superior tissue repair, compared to the wild-type proteins. Furthermore, unwanted side effects were decreased: For example, the engineered angiogenic growth factor VEGF showed reduced vascular permeability, a concern that has limited the therapeutic efficacy of wild-type VEGF.

19 March 2010 in Circulation Research
Verified
Journal Article
Closed access
PDF file
DMDimana O. Miteva
Dimana O. Miteva
JRJoseph M. Rutkowski
Joseph M. Rutkowski
BDBrandon Dixon
Brandon Dixon
WKWitold Kilarski
Witold Kilarski
JSJacqueline D. Shields
Jacqueline D. Shields
MSMelody A. Swartz
Melody A. Swartz
Rationale: Lymphatic transport of peripheral interstitial fluid and dendritic cells (DCs) is important for both adaptive immunity and maintenance of tolerance to self-antigens. Lymphatic drainage can change rapidly and dramatically on tissue injury or inflammation, and therefore increased fluid flow may serve as an important early cue for inflammation; however, the effects of transmural flow on lymphatic function are unknown. Objective: Here we tested the hypothesis that lymph drainage regulates the fluid and cell transport functions of lymphatic endothelium. Methods and Results: Using in vitro and in vivo models, we demonstrated that lymphatic endothelium is sensitive to low levels of transmural flow. Basal-to-luminal flow (0.1 and 1 μm/sec) increased lymphatic permeability, dextran transport, and aquaporin-2 expression, as well as DC transmigration into lymphatics. The latter was associated with increased lymphatic expression of the DC homing chemokine CCL21 and the adhesion molecules intercellular adhesion molecule-1 and E-selectin. In addition, transmural flow induced delocalization and downregulation of vascular endothelial cadherin and PECAM-1 (platelet/endothelial cell adhesion molecule-1). Flow-enhanced DC transmigration could be reversed by blocking CCR7, intercellular adhesion molecule-1, or E-selectin. In an experimental model of lymphedema, where lymphatic drainage is greatly reduced or absent, lymphatic endothelial expression of CCL21 was nearly absent. Conclusions: These findings introduce transmural flow as an important regulator of lymphatic endothelial function and suggest that flow might serve as an early inflammatory signal for lymphatics, causing them to regulate transport functions to facilitate the delivery of soluble antigens and DCs to lymph nodes.

24 August 2015 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
MPMaria-Giuseppina Procopio
Maria-Giuseppina Procopio
CLCsaba Laszlo
Csaba Laszlo
DLDania Al Labban
Dania Al Labban
DKDong-Eun Kim
Dong-Eun Kim
PBPino Bordignon
Pino Bordignon
GDG. Paolo Dotto
G. Paolo Dotto
Stromal fibroblast senescence has been linked to ageing-associated cancer risk. However, density and proliferation of cancer-associated fibroblasts (CAFs) are frequently increased. Loss or downmodulation of the Notch effector CSL (also known as RBP-Jκ) in dermal fibroblasts is sufficient for CAF activation and ensuing keratinocyte-derived tumours. We report that CSL silencing induces senescence of primary fibroblasts from dermis, oral mucosa, breast and lung. CSL functions in these cells as a direct repressor of multiple senescence- and CAF-effector genes. It also physically interacts with p53, repressing its activity. CSL is downmodulated in stromal fibroblasts of premalignant skin actinic keratosis lesions and squamous cell carcinomas, whereas p53 expression and function are downmodulated only in the latter, with paracrine FGF signalling as the probable culprit. Concomitant loss of CSL and p53 overcomes fibroblast senescence, enhances expression of CAF effectors and promotes stromal and cancer cell expansion. The findings support a CAF activation–stromal co-evolution model under convergent CSL–p53 control.

31 May 2009 in Nature Medicine
Verified
Journal Article
Closed access
WKWitold W Kilarski
Witold W Kilarski
BSBranka Samolov
Branka Samolov
LPLudvig Petersson
Ludvig Petersson
AKAnders Kvanta
Anders Kvanta
PGPär Gerwins
Pär Gerwins

1 November 2016 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
HHHuanhuan He
Huanhuan He
JMJulia J. Mack
Julia J. Mack
EGEsra Güç
Esra Güç
CWCarmen M. Warren
Carmen M. Warren
MSMario Leonardo Squadrito
Mario Leonardo Squadrito
MIM. Luisa Iruela-Arispe
M. Luisa Iruela-Arispe
Objective—: Perivascular cells, including pericytes, macrophages, smooth muscle cells, and other specialized cell types, like podocytes, participate in various aspects of vascular function. However, aside from the well-established roles of smooth muscle cells and pericytes, the contributions of other vascular-associated cells are poorly understood. Our goal was to ascertain the function of perivascular macrophages in adult tissues under nonpathological conditions. Approach and Results—: We combined confocal microscopy, in vivo cell depletion, and in vitro assays to investigate the contribution of perivascular macrophages to vascular function. We found that resident perivascular macrophages are associated with capillaries at a frequency similar to that of pericytes. Macrophage depletion using either clodronate liposomes or antibodies unexpectedly resulted in hyperpermeability. This effect could be rescued when M2-like macrophages, but not M1-like macrophages or dendritic cells, were reconstituted in vivo, suggesting subtype-specific roles for macrophages in the regulation of vascular permeability. Furthermore, we found that permeability-promoting agents elicit motility and eventual dissociation of macrophages from the vasculature. Finally, in vitro assays showed that M2-like macrophages attenuate the phosphorylation of VE-cadherin upon exposure to permeability-promoting agents. Conclusions—: This study points to a direct contribution of macrophages to vessel barrier integrity and provides evidence that heterotypic cell interactions with the endothelium, in addition to those of pericytes, control vascular permeability.

1 July 2017 in Biomaterials
Verified
Journal Article
Open access
EGEsra Güç
Esra Güç
PBPriscilla S. Briquez
Priscilla S. Briquez
DFDidier Foretay
Didier Foretay
MFManuel A. Fankhauser
Manuel A. Fankhauser
JHJeffrey A. Hubbell
Jeffrey A. Hubbell
MSMelody A. Swartz
Melody A. Swartz
Lymphangiogenesis occurs in inflammation and wound healing, yet its functional roles in these processes are not fully understood. Consequently, clinically relevant strategies for therapeutic lymphangiogenesis remain underdeveloped, particularly using growth factors. To achieve controlled, local capillary lymphangiogenesis with protein engineering and determine its effects on fluid clearance, leukocyte trafficking, and wound healing, we developed a fibrin-binding variant of vascular endothelial growth factor C (FB-VEGF-C) that is slowly released upon demand from infiltrating cells. Using a novel wound healing model, we show that implanted fibrin containing FB-VEGF-C, but not free VEGF-C, could stimulate local lymphangiogenesis in a dose-dependent manner. Importantly, the effects of FB-VEGF-C were restricted to lymphatic capillaries, with no apparent changes to blood vessels and downstream collecting vessels. Leukocyte intravasation and trafficking to lymph nodes were increased in hyperplastic lymphatics, while fluid clearance was maintained at physiological levels. In diabetic wounds, FB-VEGF-C-induced lymphangiogenesis increased extracellular matrix deposition and granulation tissue thickening, indicators of improved wound healing. Together, these results indicate that FB-VEGF-C is a promising strategy for inducing lymphangiogenesis locally, and that such lymphangiogenesis can promote wound healing by enhancing leukocyte trafficking without affecting downstream lymphatic collecting vessels.